Tisotumab vedotin

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Tisotumab vedotin

Aug 9, 2024, 13:35 | Blog

Wafik S. El-Deiry: Keep up with drug names mentioned in the NEJM in the last month

Wafik S. El-Deiry shared on X: "For my colleagues on MedTwitter trying to keep up with…

Jul 15, 2024, 08:52 | Blog

Raffaele Colombo: Tisotumab vedotin as 2nd or 3rd line therapy for recurrent cervical cancer

Raffaele Colombo shared a post on X about recent paper by Ignace Vergote et al.…

Jul 11, 2024, 09:55 | Insight

Piotr Wysocki: Tisotumab vedotin improves outcomes of patients with recurrent cervical cancer

Piotr Wysocki recently posted on LinkedIn: "Vergote I et al. published results of a phase III…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023